News Summary

• Robhy Bustami is co-founder and CEO of BioticsAI.
• His company is developing an AI copilot for ultrasound that helps detect fetal abnormalities.
• In January, they gained FDA approval, which means they can begin launching in hospitals.
• Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.
• The company is beginning to roll out its technology in hospitals, with plans to expand beyond obstetrics into broader areas of reproductive health.